Trailing-twelve-month (TTM) revenue is $7.39 Billion with a year-over-year growth of +9.54%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-08-31 | $1,724,900,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-07 |
| Q4 FY2025Period ended 2025-11-30 | $1,850,400,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-01-22 |
| Q1 FY2026Period ended 2026-02-28 | $1,873,900,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-31 |
| Q2 FY2026Period ended 2026-05-31 | $1,936,600,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-06-25 |
| TTM revenue | $7,385,800,000 |
Current P/S: $13,404,938,532 market capitalization ÷ $7,385,800,000 TTM revenue = 1.81x.
Market capitalization source: FMP quote. Quote observed 2026-09-15T20:00:02.000Z. Latest revenue period ended 2026-05-31.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-05-31): $1.94B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-16T10:35:45.468Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-11-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-11-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-11-29 · USD | FY20212021-11-29 · USD | FY20222022-11-30 · USD | FY20232023-11-30 · USD | FY20242024-11-30 · USD | FY20252025-11-30 · USD |
|---|---|---|---|---|---|---|
| Consumer | $3.6B | $3.9B | $3.8B | $3.8B | $3.8B | $4.0B |
| Flavor Solutions | $2.0B | $2.4B | $2.6B | $2.9B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-11-30 · USD | FY20212021-11-30 · USD | FY20222022-11-30 · USD | FY20232023-11-30 · USD | FY20242024-11-30 · USD | FY20252025-11-30 · USD |
|---|---|---|---|---|---|---|
| Americas | $4.0B | $4.4B | $4.6B | $4.8B | $4.8B | $4.9B |
| Asia Pacific | $580M | $731M | $682M | $693M |
$7.39B
$7.39 Billion
+9.54%
vs. $6.74B a year ago (TTM)
+4.15%
5 Year compound annual growth rate
1 Year
+9.54%
3 Year
+4.26%
5 Year
+4.15%
10 Year
+5.42%
15 Year
+5.22%
20 Year
+5.34%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $6.84B | +$116.60M | +1.73% |
| 2024 | $6.72B | +$61.50M | +0.92% |
| 2023 | $6.66B | +$311.70M | +4.91% |
| 2022 | $6.35B | +$32.60M | +0.52% |
| 2021 | $6.32B | +$716.60M | +12.79% |
| 2020 |
TTM Growth
+9.54%
3-Year CAGR
+4.26%
5-Year CAGR
+4.15%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-16T10:35:45.468Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $2.9B |
| $2.9B |
| $704M |
| Europe Middle East And Africa | $1.0B | $1.2B | $1.1B | $1.2B | $1.2B | $1.3B |
|---|
| $5.60B |
| +$253.90M |
| +4.75% |
| 2019 | $5.35B | +$44.60M | +0.84% |
| 2018 | $5.30B | +$572.50M | +12.10% |
| 2017 | $4.73B | +$318.80M | +7.23% |
| 2016 | $4.41B | +$115.20M | +2.68% |
